Currently, decentralized clinical trials (DCT) are in a period of rapid development, with new technologies and methods such as remote intelligent technologies, wearable devices, and electronic data capture systems continuously emerging, profoundly reshaping the traditional clinical trial landscape. To adapt to this transformative trend and promote the scientific and orderly implementation of DCT in Beijing, the "Beijing Municipal Medical Products Administration", in collaboration with ten pilot institutions, has developed the "Beijing DCT Project Management System Document Consensus" through in-depth practice and multiple rounds of discussion. This consensus, consisting of 15 management documents, establishes a standardized management framework characterized by clear roles and responsibilities, operational feasibility, and controllable quality. It represents a significant milestone in the modernization of clinical trial governance in Beijing and has formed a replicable "Beijing Experience".
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |